Sodium thiosulfate fails to reduce nitrite-induced methemoglobinemia in vitro

Academic Emergency Medicine

Volumn 10, Issue 4, 2003, Pages 299-302

  Matteucci, Michael John ^a   Reed, William Job ^b   Tanen, David Alan ^b  

^a NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

^b NONE

Author keywords

Hemoglobin; Methemoglobinemia; Sodium thiosulfate

Indexed keywords

METHEMOGLOBIN; NITRITE; SODIUM THIOSULFATE;

AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; METHEMOGLOBINEMIA; OXIMETRY; PRIORITY JOURNAL;

ANTIOXIDANTS; AREA UNDER CURVE; HUMANS; METHEMOGLOBINEMIA; PROSPECTIVE STUDIES; SODIUM NITRITE; THIOSULFATES;

EID: 0037389445     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/aemj.10.4.299     Document Type: Article

References (16)

1. Curry S. Methemoglobinemia. Ann Emerg Med. 1982; 11: 214-21.
2. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology, clinical management. Ann Emerg Med. 1999; 34:646-56.
3. Rosen PJ, Johnson G, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Ann Intern Med. 1971; 75:83-6.
4. Melville KI, Bruger M. Concerning the alleged antidotal action of sodium thiosulfate in mercuric chloride poisoning. J Pharm Exp Ther. 1929; 37:1-8.
5. Young AG, Taylor FH. The effect of sodium thiosulfate on mercury poisoning. J Pharm Exp Ther. 1931; 42:185-95.
6. Neuwelt EA, Brummett RE, Remsen LG, et al. In vitro and animal studies of sodium thiosulfate as a potential chemoprotectant against carboplatin-induced ototoxicity. Cancer Res. 1996; 56:706-9.
7. Neuwalt EA, Brummett RE, Doolittle ND, et al. First evidence of otoprotection against carboplatin-induced hearing loss with two-component system in patients with central nervous system malignancy using sodium thiosulfate. J Pharm Exp Ther. 1998; 286:77-84.
8. De Vriese A, Vanholder R, Lammeire N. Severe acute renal failure due to bromate intoxication: report of a case and discussion of management guidelines based on a review of the literature. Nephrol Dial Transplant. 1997; 12:204-9.
9. Wright RO, Woolf AD, Shannon MW, Magnani B. N-acetylcysteine reduces methemoglobin in an in-vitro model of glucose-6-phosphate dehydrogenase deficiency. Acad Emerg Med. 1998; 5:225-9.
10. Wright RO, Magnani B, Shannon MW, Woolf AD. N-acetylcysteine reduces methemoglobin in vitro. Ann Emerg Med. 1996; 5:499-503.
11. Dotsch J, Demirakca S, Kratz M, Repp R, Knerr I, Rascher W. Comparison of methylene blue, riboflavin, and N-acetylcysteine for the reduction of nitric oxide-induced methemoglobinemia. Crit Care Med. 2000; 28:958-61.
12. Tanen DA, LoVecchio F, Curry SC. Failure of intravenous N-acetylcysteine to reduce methemoglobin produced by sodium nitrite in human volunteers: a randomized controlled trial. Ann Emerg Med. 2000; 35:369-73.
13. Frankenberg L. Enzyme therapy in cyanide poisoning: effect of rhodanese and sulfur compounds. Arch Toxicol. 1980; 45:315-23.
14. Sylvester DM, Hayton WL, Morgan RL, Way JL. Effects of thiosulfate on cyanide pharmacokinetics in dogs. Toxicol Appl Pharmacol. 1983; 69:265-71.
15. Hall AH, Rumack BH. Hydroxycobalamin/sodium thiosulfate as a cyanide antidote. J Emerg Med. 1987; 5:115-21.
16. Baskin SI, Horowitz AM, Nealley EW. The antidotal action of sodium nitrite and sodium thiosulfate against cyanide poisoning. J Clin Pharmacol. 1992; 32:368-75.